全文获取类型
收费全文 | 24930篇 |
免费 | 1916篇 |
国内免费 | 761篇 |
专业分类
耳鼻咽喉 | 79篇 |
儿科学 | 364篇 |
妇产科学 | 185篇 |
基础医学 | 5546篇 |
口腔科学 | 1575篇 |
临床医学 | 1474篇 |
内科学 | 3446篇 |
皮肤病学 | 339篇 |
神经病学 | 2130篇 |
特种医学 | 372篇 |
外国民族医学 | 3篇 |
外科学 | 1864篇 |
综合类 | 2472篇 |
现状与发展 | 3篇 |
预防医学 | 1384篇 |
眼科学 | 199篇 |
药学 | 4313篇 |
2篇 | |
中国医学 | 787篇 |
肿瘤学 | 1070篇 |
出版年
2024年 | 59篇 |
2023年 | 323篇 |
2022年 | 698篇 |
2021年 | 1038篇 |
2020年 | 773篇 |
2019年 | 740篇 |
2018年 | 731篇 |
2017年 | 713篇 |
2016年 | 818篇 |
2015年 | 888篇 |
2014年 | 1427篇 |
2013年 | 1766篇 |
2012年 | 1456篇 |
2011年 | 1700篇 |
2010年 | 1307篇 |
2009年 | 1245篇 |
2008年 | 1281篇 |
2007年 | 1147篇 |
2006年 | 1020篇 |
2005年 | 787篇 |
2004年 | 690篇 |
2003年 | 705篇 |
2002年 | 488篇 |
2001年 | 433篇 |
2000年 | 363篇 |
1999年 | 341篇 |
1998年 | 353篇 |
1997年 | 394篇 |
1996年 | 304篇 |
1995年 | 303篇 |
1994年 | 268篇 |
1993年 | 259篇 |
1992年 | 231篇 |
1991年 | 249篇 |
1990年 | 229篇 |
1989年 | 199篇 |
1988年 | 190篇 |
1987年 | 182篇 |
1986年 | 186篇 |
1985年 | 241篇 |
1984年 | 211篇 |
1983年 | 131篇 |
1982年 | 205篇 |
1981年 | 136篇 |
1980年 | 93篇 |
1979年 | 71篇 |
1978年 | 59篇 |
1977年 | 57篇 |
1976年 | 32篇 |
1975年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
胰岛素样生长因子-1在妇科疾病中的作用 总被引:8,自引:3,他引:5
在许多组织增生过程中,通过内分泌、旁分泌和自分泌会产生胰岛素样生长因子-1(IGF-1)。最近的研究发现,IGF-1存在于各种增生组织,如子宫内膜和卵巢组织。患有严重子宫内膜异位症时,血清中IGF-1水平较高,而子宫内膜局部的:IGF-1水平减低,这可能是导致不孕的原因,多囊性卵巢综合征(PCOS)患者卵巢局部的IGF-1活性增强,与患者肥胖、高雄激素水平等一系列临床症状有关。IGF-1在良、恶性肿瘤中也起着重要的作用,IGF-1能刺激子宫肌瘤细胞的生长。围绝经期妇女若存在高IGF-1和低IGF-1结合蛋白-3(IGFBP-3)水平,则患乳腺癌的风险增大。绝经前后女性的高IGF-1水平与宫颈癌、卵巢癌和子宫内膜癌的发病率存在相关性。 相似文献
72.
73.
Objective To evaluate the association of 2616c/T polymorphism in iron regulatory protein 2(IRP2)gene with Alzheimer disease(AD)and Vascular dementia(VD).Methods In this study,281 patients with AD,60 with VD,and 285 normal aged were recruited.The 2616C/T polymorphism in IRP2 gene was analyzed by using polymerase chain reaction-restriction fragment length polymorphism.And the cognitive function was assessed with the Mini-Mental State Examination(MMSE).Results (1)No significant difieFences were demonstrated in IRP2 genotype or allele frequencies between AD patients and controls(χ2=2.46,P=0.292;χ2=2.17,P=0.141 respectively).However,when AD patients were stratified by disease severity.the frequency of T allele carriers in the moderate to severe AD patients was 78.0%,significantly higher than that in controls(69.8%;χ2=4.106,P<0.05).Logistic regression analysis demonstrated that the age-,sex-and ApoE-adiusted OR of modcrate to severe AD patient with T allele was 1.62(95% CI=1.03-2.54).The frequency of T allele carriers or T allele in VD patients was higher than that of controls,but the difference was not statistically significant(P>0.05).(2)The frequency of tit genotype or T allele in the moderate to severe AD patients was significantly higher than that in mild AD patients(25.8%vs.12.5%,χ2=5.477,P<0.05;51.9%vs.40.3%,χ2=5.803,P<0.05 respectively).(3)MMSE scores of the AD patients with TT genotype was significantly lower than ones with CC or CT genotype(P=0.028;P=0.014 respectively).Conclusion The 2616C/T polymorphism in the IRP2 gene is possibly associated with moderate to severe AD.but not associated with VD.And the TT genotype may be a risk factor for cognitive impairment of patients with AD in Chinese Han. 相似文献
74.
J Dissemond D Haberer T Franckson U Hillen 《Journal of the European Academy of Dermatology and Venereology》2004,18(5):611-613
The Van der Woude syndrome is a rare autosomal dominant developmental malformation usually associated with bilateral lower lip pits. These congenital lip pits appear clinically as a malformation in the vermilion border of the lip, with or without excretion. As a genetic defect has been identified as a microdeletion of chromosome bands 1q32-q41, genetic counselling of patients may be considered. A nonsense mutation in the interferon regulatory factor-6 (IRF-6) is discussed as a pathogenic relevant factor. Therapeutic intervention is generally not necessary, although surgical excision is especially indicated in patients with recurrent inflammation. Physicians should be aware of the Van der Woude syndrome because it has been reported to be associated with a variety of malformations or other congenital disorders. 相似文献
75.
Jonas Bergstrm Mahmood Ahmed Jian Li Tashfeen Ahmad Andris Kreicbergs Mariana Spetea 《Journal of orthopaedic research》2006,24(6):1193-1199
Using immunohistochemical and biochemical techniques, the occurrence of endogenous opioid peptides and their receptors in normal rat bone and joint tissues was investigated. Opioid receptors were detected, quantified, and characterized in homogenates from capsule/synovium and periosteum using radioligand binding assays. Receptor binding of the nonselective opioid [3H]naloxone to tissue homogenates was stereospecific and saturable, showing similar characteristics to that of brain tissue, although with lower binding capacities. By immunohistochemistry, the neuronal occurrence of four different enkephalins was demonstrated in synovium, bone marrow, periosteum, and juxta-articular bone, whereas no neuronal dynorphin immunoreactivity was detected. Double-staining studies disclosed that enkephalins coexisted with substance P in primary afferent fibers. The applied techniques can be used to assess changes in the distribution of endogenous opioids and their receptors in joint tissues in conditions associated with pain and inflammation. The endogenous opioid system now demonstrated might be targeted and exploited therapeutically to obtain peripheral control of symptoms in joint disorders. 相似文献
76.
六味地黄冲剂对肾阴虚病人血浆中锌铜含量的影响 总被引:1,自引:0,他引:1
肾阴虚病人血浆中锌、铜含量均较正常人血浆中锌,铜含量明显增高(P<0.01)。男女性别间本组未见差异。服用治疗肾阴虚药物六味地黄3种剂型后均使锌,铜含量明显降低(P<0.01),六味地黄冲剂与汤剂效果一致。 相似文献
77.
SEVERO SALVADORI REMO GUERRINI PIERO ANDREA BOREA ROBERTO TOMATIS 《Chemical biology & drug design》1992,40(5):437-444
The synthesis of pseudotetrapeptides H-Tyr-D-Ala-Phe-NH-(CH2)2-NH2 (1a), H-Tyr-D-Ala-Phe-ψ(CH2-NH)-Gly-NH2 (2a), H-Tyr-D-Ala-ψ(CH2-NH)-Phe-Gly-NH2 (3a), and H-Tyr-ψ(CH2-NH)-D-Ala-Phe-Gly-NH2 (4a), representing the N-terminal tetrapeptide sequence of dermorphin, in which amide bonds are replaced by CH2-NH bond, is described. N-acetyl-Tyr and desamino-Tyr pseudopeptide analogs (1-4b), (1-3c) are also described. The analogs were assayed in binding studies based on displacement of μ and δ-receptor selective radiolabels from rat brain membrane and in a bioassay using guinea pig ileum (GPI). Pseudopeptides in which the C-terminal (1a) or D-Ala-Phe (3a) amide bond are substituted, exhibit higher μ-affinities and μ-receptor selectivity than the corresponding Phe-Gly or Tyr-D-Ala analogs (2a, 4a). Acetyl-and desamino-Tyr pseudopeptide analogs (1-4b) and (1-3c) did not exhibit μ and δ-opioid receptor affinity at nM concentration. The relevance of the single peptide replacement and of its association to acetylation or amino group elimination of Tyr, is discussed on the basis of a receptor model for μ and δ opioids. 相似文献
78.
Summary A series of in vivo experiments were undertaken, relating functional (motor activity, body temperature), dopamine (DA) receptor binding and neurochemical (catecholamine synthesis and utilization, DA release) aspects of the pharmacology of SCH 23390 in the rat.The compound inhibited the locomotor hyperactivity, but not the hypothermia, induced by the potent DA stimulant DP-5,6-ADTN. Interstingly, SCH 23390 simultaneously failed to displace DP-5,6-ADTN from its binding sites in the rat striatum—used as a direct in vivo biochemical index of DA (D-2) receptor interaction. The spontaneous locomotion in non-pretreated rats was likewise inhibited by SCH 23390. The locomotor-suppressive action, but not the DP-5,6-ADTN-displacing capcity of the D-2 blocker haloperidol was significantly enhanced by SCH 23390, suggesting that motility can be suppressed by either enhanced D-1 or D-2 (postsynaptic) receptor blockade, but also that the D-1 and D-2 sites involved may be physically distinct.SCH 23390 only slightly altered in vivo neurochemical of DA synthesis, release and nerve-impulse flow, indicating that, while similar in suppressing dopaminergic behaviour, the D-1 antagonist is less effective than traditional neuroleptics as an activator of DA neuronal feedback mechanisms. The weak increases of DA synthesis and release nonetheless obtained were equal in magnitude (30–40%) in the limbic vs. striatal brain areas; also in this respect, SCH 23390 thus differs from classical neuroleptics, which generally display more marked effects in the striatum than in limbic tissue.No major changes in the in vivo indices of NA synthesis and utilization (or in 5-HT synthesis) were found after SCH 23390 administration, by and large supporting the DA receptor specificity of the compound.In summary, the studies demonstrated that SCH 23390 can offset and accentuate, respectively, behavioural consequences of D-2 receptor stimulation and blockade. Importantly, at the same time no direct interaction at the level of D-2 DA receptor sites in the striatum was detected. Only slight, D-2 antagonist-like, changes in neurochemical indices of dopaminergic activity were observed after D-1 receptor blockade by means of SCH 23390. With regard to DA agonist hypothermia, SCH 23390 was without effect per se, but (at a high dose) attenuated the action of the D-2 antagonist haloperidol. The observations may indicate that the complex interactions between central D-1 and D-2 receptor-controlled mechanisms that influence behaviour, neurochemistry, and possibly autonomic nervous expression, are not identical. 相似文献
79.
80.